newsfilter
← Latest News
GlobeNewswire·

Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations

  • UNC Health OB/GYNs will become the first within the system to offer FemVue fertility evaluation & FemaSeed as a first-line treatment option.
  • Femasys Inc. announced a partnership with UNC Health to introduce FemVue, SpermVue, & FemaSeed Complete within UNC Health OB/GYN practice locations.
  • FemVue uses ultrasound to assess fallopian tube patency, while SpermVue provides an at-home male fertility screening option.
  • FemaSeed Complete enables in-office intratubal insemination without the need for specialist referral or outside laboratory services.
  • Dr. John "Jack" Coiner II advocates for the technology to reduce barriers for patients in the High Country of North Carolina who currently face long travel distances to fertility specialists.
  • The collaboration aims to bring fertility evaluation & treatment earlier in the care pathway, allowing patients to begin care sooner with trusted local physicians.
  • Femasys is also advancing FemBloc, a non-surgical permanent birth control solution, through the ongoing FINALE pivotal trial after receiving regulatory approvals in Europe, the UK, & New Zealand in 2025.
  • UNC Health is North Carolina's largest academic health system, combining community-based services with the clinical expertise of the UNC School of Medicine.